Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2016

09.09.2016 | Colorectal Cancer

Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base

verfasst von: Adan Z. Becerra, BA, Mariana E. Berho, MD, Christian P. Probst, MD, MPH, Christopher T. Aquina, MD, MPH, Mohamedtaki A. Tejani, MD, Maynor G. Gonzalez, PhD, Zhaomin Xu, MD, Alex A. Swanger, BA, Katia Noyes, PhD, MPH, John R. Monson, MD, Fergal J. Fleming, MD

Erschienen in: Annals of Surgical Oncology | Sonderheft 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about between-hospital differences in the rate of suboptimal lymphadenectomy. This study characterizes variation in hospital-specific rates of suboptimal lymphadenectomy and its effect on overall survival in a national hospital-based registry.

Methods

Stage I–III colon cancer patients were identified from the 2003–2012 National Cancer Data Base. Bayesian multilevel logistic regression models were used to assess the impact of patient- and hospital-level factors on hospital-specific rates of suboptimal lymphadenectomy (<12 lymph nodes), and multilevel Cox models were used to estimate the effect of suboptimal lymphadenectomy at the patient (yes vs. no) and hospital level (quartiles of hospital-specific rates) on overall survival.

Results

A total of 360,846 patients across 1345 hospitals in the US met the inclusion criteria, of which 25 % had a suboptimal lymphadenectomy. Wide variation was observed in hospital-specific rates of suboptimal lymphadenectomy (range 0–82 %, median 44 %). Older age, male sex, comorbidity score, no insurance, positive margins, lower tumor grade, lower T and N stage, and sigmoid and left colectomy were associated with higher odds of suboptimal lymphadenectomy. Patients treated at lower-volume and non-academic hospitals had higher odds of suboptimal lymphadenectomy. Patient- and hospital-level factors explained 5 % of the between-hospital variability in suboptimal lymphadenectomy, leaving 95 % unexplained. Higher suboptimal lymphadenectomy rates were associated with worse survival (quartile 4 vs. quartile 1: hazard ratio 1.19, 95 % confidence interval 1.16–1.22).

Conclusion

Large differences in hospital-specific rates of suboptimal lymphadenectomy were observed, and this variation was associated with survival. Quality improvement initiatives targeting hospital-level adherence to the national standard may improve overall survival among resected colon cancer patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AL. AJCC Cancer Staging Manual. Springer, New York, 2009. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AL. AJCC Cancer Staging Manual. Springer, New York, 2009.
3.
Zurück zum Zitat Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRefPubMed Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17(6):1471–4.CrossRefPubMed
4.
Zurück zum Zitat Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458–63.CrossRefPubMedPubMedCentral Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458–63.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84:120–6.CrossRefPubMed Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84:120–6.CrossRefPubMed
6.
Zurück zum Zitat Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433–41.CrossRefPubMed Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433–41.CrossRefPubMed
7.
Zurück zum Zitat Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602–10.PubMedPubMedCentral Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602–10.PubMedPubMedCentral
8.
Zurück zum Zitat Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93:439–45.CrossRefPubMed Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol. 2006;93:439–45.CrossRefPubMed
9.
Zurück zum Zitat Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.CrossRefPubMed Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.CrossRefPubMed
10.
Zurück zum Zitat Buyse M, Sargent DJ, Grothey A, Matheson A, de Gramont A. Biomarkers and surrogate end points–the challenge of statistical validation. Nat Rev Clin Oncol. 2010;7:309–17.CrossRefPubMed Buyse M, Sargent DJ, Grothey A, Matheson A, de Gramont A. Biomarkers and surrogate end points–the challenge of statistical validation. Nat Rev Clin Oncol. 2010;7:309–17.CrossRefPubMed
11.
Zurück zum Zitat Storli K, Søndenaa K, Furnes B, et al. Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III. World J Surg. 2011;35(12):2796–803.CrossRefPubMed Storli K, Søndenaa K, Furnes B, et al. Improved lymph node harvest from resected colon cancer specimens did not cause upstaging from TNM stage II to III. World J Surg. 2011;35(12):2796–803.CrossRefPubMed
12.
Zurück zum Zitat Oshea A, Aly O, Parnaby CN, Loudon MA, Samuel LM, Murray GI. Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers. PLoS One. 2014;9(8):e104991.CrossRefPubMedPubMedCentral Oshea A, Aly O, Parnaby CN, Loudon MA, Samuel LM, Murray GI. Increased lymph node yield in colorectal cancer is not necessarily associated with a greater number of lymph node positive cancers. PLoS One. 2014;9(8):e104991.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pNo. Cancer. 2001;92:452.CrossRefPubMed Sobin LH, Greene FL. TNM classification: clarification of number of regional lymph nodes for pNo. Cancer. 2001;92:452.CrossRefPubMed
14.
Zurück zum Zitat Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979–94.PubMed Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979–94.PubMed
15.
Zurück zum Zitat National Comprehensive Cancer Network. National Clinical Practice Guidelines in Oncology. NCCN, 2011. National Comprehensive Cancer Network. National Clinical Practice Guidelines in Oncology. NCCN, 2011.
16.
Zurück zum Zitat Monson JR, Probst CP, Wexner SD, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260(4):625–31.CrossRefPubMed Monson JR, Probst CP, Wexner SD, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260(4):625–31.CrossRefPubMed
17.
Zurück zum Zitat Becerra AZ, Probst CP, Tejani MA, et al. Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused. Surgery. 2015;158(3):692–9.CrossRefPubMed Becerra AZ, Probst CP, Tejani MA, et al. Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused. Surgery. 2015;158(3):692–9.CrossRefPubMed
18.
Zurück zum Zitat Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS, Ko CY. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008;206:247–54.CrossRefPubMed Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS, Ko CY. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008;206:247–54.CrossRefPubMed
19.
Zurück zum Zitat Nedrebø BS, Søreide K, Nesbakken A, et al. Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort. Colorectal Dis. 2013;15(6):e301–8.CrossRefPubMed Nedrebø BS, Søreide K, Nesbakken A, et al. Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort. Colorectal Dis. 2013;15(6):e301–8.CrossRefPubMed
20.
Zurück zum Zitat Wright FC, Law CH, Berry S, Smith AJ. Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol. 2009;99:248–55.CrossRefPubMed Wright FC, Law CH, Berry S, Smith AJ. Clinically important aspects of lymph node assessment in colon cancer. J Surg Oncol. 2009;99:248–55.CrossRefPubMed
21.
Zurück zum Zitat Moro-valdezate D, Pla-martí V, Martín-arévalo J, et al. Factors related to lymph node harvest: does a recovery of more than 12 improve the outcome of colorectal cancer?. Colorectal Dis. 2013;15(10):1257–66.CrossRefPubMed Moro-valdezate D, Pla-martí V, Martín-arévalo J, et al. Factors related to lymph node harvest: does a recovery of more than 12 improve the outcome of colorectal cancer?. Colorectal Dis. 2013;15(10):1257–66.CrossRefPubMed
22.
Zurück zum Zitat Mcdonald JR, Renehan AG, O’Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg. 2012;4(1):9–19.CrossRefPubMedPubMedCentral Mcdonald JR, Renehan AG, O’Dwyer ST, Haboubi NY. Lymph node harvest in colon and rectal cancer: current considerations. World J Gastrointest Surg. 2012;4(1):9–19.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Nathan H, Shore AD, Anders RA, Wick EC, Gearhart SL, Pawlik TM. Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J Gastrointest Surg. 2011;15(3):471–9.CrossRefPubMed Nathan H, Shore AD, Anders RA, Wick EC, Gearhart SL, Pawlik TM. Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital? J Gastrointest Surg. 2011;15(3):471–9.CrossRefPubMed
24.
Zurück zum Zitat Rhoads KF, Ackerson LK, Ngo JV, Gray-Hazard FK, Subramanian SV, Dudley RA. Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon. Med Care. 2013;51(12):1055–62.CrossRefPubMed Rhoads KF, Ackerson LK, Ngo JV, Gray-Hazard FK, Subramanian SV, Dudley RA. Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon. Med Care. 2013;51(12):1055–62.CrossRefPubMed
25.
Zurück zum Zitat Parsons HM, Begun JW, Kuntz KM, Tuttle TM, Mcgovern PM, Virnig BA. Lymph node evaluation for colon cancer in an era of quality guidelines: who improves? J Oncol Pract. 2013;9(4):e164–71.CrossRefPubMedPubMedCentral Parsons HM, Begun JW, Kuntz KM, Tuttle TM, Mcgovern PM, Virnig BA. Lymph node evaluation for colon cancer in an era of quality guidelines: who improves? J Oncol Pract. 2013;9(4):e164–71.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.CrossRefPubMed
28.
Zurück zum Zitat Gelman A, Hill J. Data analysis using regression and multilevel/hierarchical models. Cambridge University Press, Cambridge, 2007. Gelman A, Hill J. Data analysis using regression and multilevel/hierarchical models. Cambridge University Press, Cambridge, 2007.
29.
Zurück zum Zitat Finch WH, Bolin JE, Kelley K. Multilevel modeling using R. CRC Press, Boca Raton, 2014. Finch WH, Bolin JE, Kelley K. Multilevel modeling using R. CRC Press, Boca Raton, 2014.
30.
Zurück zum Zitat Snijders TA, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. Sage Publications Ltd, Los Angeles, 2011.CrossRef Snijders TA, Bosker RJ. Multilevel analysis: an introduction to basic and advanced multilevel modeling. Sage Publications Ltd, Los Angeles, 2011.CrossRef
31.
Zurück zum Zitat Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290–7.CrossRefPubMedPubMedCentral Merlo J, Chaix B, Ohlsson H, et al. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290–7.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Rosenbaum PR. Observational studies. Springer-Verlag, New York, 2002.CrossRef Rosenbaum PR. Observational studies. Springer-Verlag, New York, 2002.CrossRef
33.
Zurück zum Zitat Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–8. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33–8.
34.
Zurück zum Zitat Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33(6):1057–69.CrossRefPubMed Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33(6):1057–69.CrossRefPubMed
35.
Zurück zum Zitat Jarrod D Hadfield. MCMC methods for multi-response generalized linear mixed models: the MCMCglmm R Package. J Stat Softw. 2010;33(2):1–22. Jarrod D Hadfield. MCMC methods for multi-response generalized linear mixed models: the MCMCglmm R Package. J Stat Softw. 2010;33(2):1–22.
37.
Zurück zum Zitat Bamboat ZM, Deperalta D, Dursun A, Berger DL, Bordeianou L. Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis. 2011;26(9):1163–8.CrossRefPubMed Bamboat ZM, Deperalta D, Dursun A, Berger DL, Bordeianou L. Factors affecting lymph node yield from patients undergoing colectomy for cancer. Int J Colorectal Dis. 2011;26(9):1163–8.CrossRefPubMed
38.
Zurück zum Zitat Xynos E, Gouvas N, Triantopoulou C, et al. Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO. Ann Gastroenterol. 2016;29(1):3–17.PubMedPubMedCentral Xynos E, Gouvas N, Triantopoulou C, et al. Clinical practice guidelines for the surgical management of colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO. Ann Gastroenterol. 2016;29(1):3–17.PubMedPubMedCentral
39.
Zurück zum Zitat Rieger NA, Barnett FS, Moore JW, et al. Quality of pathology reporting impacts on lymph node yield in colon cancer. J Clin Oncol. 2007;25:463 (author reply 463–4).CrossRefPubMed Rieger NA, Barnett FS, Moore JW, et al. Quality of pathology reporting impacts on lymph node yield in colon cancer. J Clin Oncol. 2007;25:463 (author reply 463–4).CrossRefPubMed
40.
Zurück zum Zitat Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149–54.CrossRefPubMed Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298(18):2149–54.CrossRefPubMed
41.
Zurück zum Zitat Parsons HM, Tuttle TM, Kuntz KM, Begun JW, Mcgovern PM, Virnig BA. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306(10):1089–97.CrossRefPubMed Parsons HM, Tuttle TM, Kuntz KM, Begun JW, Mcgovern PM, Virnig BA. Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA. 2011;306(10):1089–97.CrossRefPubMed
42.
Zurück zum Zitat Wong SL. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. JAMA. 2011;306(10):1139–41.CrossRefPubMed Wong SL. Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. JAMA. 2011;306(10):1139–41.CrossRefPubMed
Metadaten
Titel
Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base
verfasst von
Adan Z. Becerra, BA
Mariana E. Berho, MD
Christian P. Probst, MD, MPH
Christopher T. Aquina, MD, MPH
Mohamedtaki A. Tejani, MD
Maynor G. Gonzalez, PhD
Zhaomin Xu, MD
Alex A. Swanger, BA
Katia Noyes, PhD, MPH
John R. Monson, MD
Fergal J. Fleming, MD
Publikationsdatum
09.09.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe Sonderheft 5/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5551-2

Weitere Artikel der Sonderheft 5/2016

Annals of Surgical Oncology 5/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.